Vanguard Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.76M Hold
1,534,847
– – ﹤0.01% 3172
2026
Q2
$6.89M Sell
1,534,847
-20,425
-1% -$81K ﹤0.01% 2995
2026
Q1
$5.74M Buy
+1,555,272
New +$5.81M ﹤0.01% 3002

Other funds holding APYX

Vanguard Capital Management's APYX Position: Q3 2026 in Review

Vanguard Capital Management held its Apyx Medical (APYX) position steady in Q3 2026 at 1,534,847 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3172.

Vanguard Capital Management first reported a position in APYX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.89M in Q2 2026. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2026.

  • Vanguard Capital Management held 1,534,847 shares of Apyx Medical worth $3.76M as of Q3 2026.
  • Vanguard Capital Management left its Apyx Medical share count unchanged in Q3 2026.
  • Apyx Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3172 holding.
  • Vanguard Capital Management first reported a position in Apyx Medical in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Apyx Medical position peaked at $6.89M in Q2 2026.
  • 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.